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Abstract:  
Bioanalytical method development plays importance role in the pre-clinical and clinical studies. Pharmacokinetics 
of any drug and its metabolite can be recognized by bioanalytical studies. The quantitative analysis of drugs and 
their metabolite sin the biological media is done by bioanalytical studies. Physical-chemical and biological 
techniques are used for these studies. Every bioanalytical method should be selective, sensitive and reliable for the 
quantitative estimation in drug discovery process. Bioanalytical method development consists of sample 
preparation, chromatographic separation and detection by using proper analytical method.  Each developed method 
should be validated as per the regulatory authorities, so as to give reliable and reproducible method for the 
intended use. Many analytical techniques can be used for bioanalysis; LCMS/MS is one of them. In Liquid 
chromatography-mass spectrometry [LC-MS/MS] the separation of analyte is done by LC and detection is carried 
out by MS. LC-MS/MS obviously used in estimation and understanding of bioavailability, bioequivalence and 
pharmacokinetic data. This review additionally centered on different validation parameters such as: accuracy, 
precision, sensitivity, selectivity, standard curve, limits of quantification, range, recovery stability, etc. 
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INTRODUCTION: 
Bioanalytical Methods are broadly engaged for the 
quantitative analysis of the drugs.[1] High penetrating 
and ultra-fast high performance liquid 
chromatography and tandem mass spectrometry [LC–
MS/MS] assay is developed and validated for the 
quantification in human plasma.[2]  Bioanalysis is 
the method to study the concentration of analyte, 
their metabolites and endogenous elements in 
biological matrix’s such as blood, plasma, serum, 
urine, and saliva. The situation also plays an main 
role in the evaluation of bioavailability, 
bioequivalence, pharmacokinetics studies.[1]  
Pre-clinical and clinical department support the 
bioanalytical process. Pre-clinical regulatory 
including Good Laboratories Practices [GLP]. Tuned 
to compound requires extensive method development 
but could leverage preclinical methods. Validation 
strategy is provided in clinical department in 
bioanalysis. Clinical and Non-clinical bioanalytical 
method development [MD] activities do not 
mandatory to be completed in compliance with GLPs 
however sufficiently documented to support a 
reproducible method document intended for 
validation.[3] Analytical techniques utilized for the 
quantitative assurance of analyte and their 
metabolites in biological samples are the key 
determinants in generating reproducible and reliable 
information data which thus are utilized in the 
assessment and understanding of bioavailability, 
bioequivalence, and pharmacokinetic discoveries [4]. 
LC-MS/MS is an amazing scientific procedure for 
quantitative bioanalysis because of its inherent high 
sensitivity and selectivity. It is susceptible, be that as 
it may, to matrix effects. The effect of lattice impacts 
on the accuracy, precision and robustness of 
bioanalytical methods is of increasing concern in the 
pharmaceutical company. The majority of the above 
components can cause critical errors in the accuracy 
and precision of bioanalytical procedures. Present 
FDA guidance documents currently need that this 
impact be evaluated as a part of quantitative 
LC/MS/MS method development, validation and 
routine use. The sample preparation and 
chromatographic methods for their adequacy in 
reducing or removing matrix effects, important to the 
greatest robust, sensitive assay possible.[5]. Liquid 
chromatography [LC] coupled by an atmospheric 
pressure ionization source to tandem mass 
spectrometric [MS/MS] detection is as of now 
considered as the method of excellent for quantitative 
analysis of compounds in biological matrixes. The 
benefits of utilizing MS/MS in the selected reaction 
monitoring mode are mostly the improved specificity, 
sensitivity.[6] 
Bioavailability is characterized as the rate and degree 
to which the active component or active moiety is 
ingested from a drug and becomes accessible at the 
site of action. For drug products that are not 
intentional to be absorbed into the bloodstream, 
bioavailability might be surveyed by estimations 
planned to duplicate the rate and degree to which the 
active components or active moiety winds up 
obtainable on the site of action. This definition 
centers around the procedures by which the active 
components or moieties are discharged from a dosage 
form and travel to the site of action.[7]  
Bioequivalence is characterized as “The 
nonappearance of a significant alteration in the rate 
and degree to which the active components or active 
moiety in pharmaceutical counterparts becomes 
obtainable at the site of drug action when managed at 
the similar molar dose under comparable situations in 
an properly designed study.”[7] 
METHOD DEVELOPMENT: 
Bioanalytical method development activities are not 
required to be performed in consistence with GLPs 
however ought to be satisfactorily documented to 
help a reproducible method document for validation. 
Method development is intended to define the 
method and provide sound scientific evidence for 
method design and suitability for its intended 
purpose.[8]The method development under search 
literature and identification physical, chemical 
properties of drug. Mass spectrometry was a fairly 
routine tool for molecular weight determination and a 
specialty tool for complex structure identification 
problems. The survey of literature checking 
pharmacokinetic profile, identification of the 
structure , molecular weight, molecular formula, drug 
dose, protein binding and solubility. The method 
development is identification of analytical 
technique.[9] Analytical technology leads to 
improvements in sensitivity & selectivity. Selection 
of tools based on nature of analytes, analytical 
sensitivity, selectivity etc, sample matrix & sample 
stability. In addition, stability of analytes needs to be 
considered from time of sample collection through 
final analytical measurement.[3] The reliability of the 
method was assessed based on linearity, sensitivity, 
selectivity, precision and accuracy, recovery and 
carry over effect. Based on the results acquired for 
the above parameters.[2] 
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Flow chart of method development 
 
Leatratutre survey
Collect information for physical 
chemical properties of drug 
Determine solubility profile of drug
Scaning in MS/MS
Selection of Mobile phase
Selection of Extraction Method or 
process and Optimize
selection of chromatographic condition 
or method depending on solubility and 
retention of drug
Reverse chromatography or Normal 
phase chromatography
Trials in deffrent chromatographic 
condition
Selection of Extraction technique and 
optimization
Finalize the method
Finally check method for linearity 
parameter
Finally Validate the method
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Drug Extraction Techniques:  
Method of extraction is the important role play in 
bioanalytical method development and validation. 
 
Solid Phase Extraction: 
Sample preparation is an essential module of 
analytical techniques. It is used to concentrate an 
drugs to increase its limits of detection, as well as to 
separate an analyte from undesirable matrix 
components that can cause interferences upon 
analysis.[10] Solid phase extraction [SPE] is an 
extraction technique based on the selective 
partitioning of one or more compounds between two 
phases, one of which is a solid sorbent. Solid phase 
extraction [SPE] is an extraction method that uses a 
solid and liquid phase to separate one, or more type, 
of drug from a solution and is used to remove certain 
compounds from a mixture of impurities based on 
their physical and chemical properties[11].The SPE 
better than other type of sample preparation 
technique such as, LLE [Liquid- Liquid Extraction] 
and protein precipitation.  SPE [Solid Phase 
Extraction] is an effective technique, often achieving 
higher recovery of analyte than other methods of 
sample preparation for the reason that of selectivity. 
The chemistry of attraction between an analyte and 
the solid sorbent can be demoralized by pH and 
solvent considerations to allow interaction yet 
eliminate interventions.[10] . In SPE small plastic 
expandable column or cartridge pressed with 0.1 to 
0.5 g of sorbent which is generally RP material [C18 
or C8] is utilized. The analyte may either specially 
adsorbed to the strong, or they may stay in the liquid 
phase.[1] 
 
Step of Solid Phase Extraction 
1) Conditioning 
2)  Loading 
3) Washing 
4) Elution 
 
1) Conditioning 
Conditioning is normally activation of the 
column. The organic solvents perform as a 
wetting agents. The organic solvent are used 
in drug related functional group. For proper 
adsorption 5% methanol and water is added 
the activation of column. 
 
2) Loading 
The aliquot sample is loaded in cartridge. 
  
3) Washing 
After the sample loading, wash the column. 
Matrix is remove and drug remain.  
  
4) Elution 
Elution for the suitable  organic solvent or 
buffer used. Which elute the drug from the 
SPE analysis.[12] 
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TYPE CARTRIDGE: 
1) Reversed Phase Extraction 
Reversed phase partitions include a polar [water] or 
decently polar sample matrix [versatile phase] and a 
nonpolar stationary phase. The analyte of intrigue is 
ordinarily mid-to non-polar. its knowledge to most 
liquid chromatographers, the number and variability 
of profitable phases available, and the large number 
of published applications. Reversed-phase 
chromatography can be utilized to isolated nonpolar, 
polar, and ionic compounds some of the time in a 
similar detachment. The technique also can complete 
a upper range of separations than all other modes 
combined since it allows users to operate the mobile 
phase by changing organic solvent type, solvent 
composition, and pH. 
Polymeric materials such as poly styrene–
divinylbenzene [PS–DVB] discovery certain usage as 
reversed-phase media [for Eg, with high-pH mobile 
phases] but commonly arrange for lower column 
efficacies than those of silica gel–based packing. 
Water, normally buffered, blended with a water-
miscible organic dissolvable [solvent, modifier], most 
generally acetonitrile or methanol, is the favored 
mobile phase. Reversed phase chromatography 
usually is performed using octadecyldimethylsilane 
[C18] or octyldimethylsilane [C8] stationary phases 
bonded to high-purity, spherical silica gel.[13] 
   
2) Normal Phase extraction 
Normal phase SPE strategies regularly incorporate a 
polar analyte, a mid to nonpolar matrix [e.g. acetone, 
hexane, chlorination solvents], and a polar stationary 
stage. Retention of an analyte under ordinary phase 
conditions is predominantly because of interactions 
among polar functional groups of the analyte and 
polar groups on the sorbent surface.[14] 
3) Ion Exchange extraction 
The SPE can be used in compound charge in specific 
solution but sometime organic solution. Ion 
suppression of drug response is a main source of in 
accuracy for bioanalytical analysis by using LC–
MS/MS. Endogenous phospholipids cause ion 
suppression in both positive ESI and negative ESI 
modes and fundamental to be settled [resolved] 
chromatographically.[14] 
1) Anion Exchange: The ion are negatively 
charged and compound are isolated on 
SAX  NH₂ bonded silica. The SAX 
material contains aliphatic amine group 
is bonded in silica base surface.[15] 
2) Cation Exchange: The ions are 
positively charged and compound are 
isolated on SCX or WCX bonded silica. 
The SCX material contains aliphatic 
sulfonic acid group bonded in silica 
base surface.[14] 
Liquid-Liquid Extraction 
The distribution of a solute depends on its preference 
for one or the other liquid, which is closely related to 
its solubility in each one of them. The common 
subject of solubilities is very high relevant to solvent 
extraction. 
Many solvent are used in liquid-liquid extraction. 
They can be divided into five different classes as 
follows  
 
Class- 1 liquid capable of forming three dimensional 
of strong hydrogen bonds, e.g; water, poly-amino 
alcohol, hydroxyl acid etc. 
 
Class- 2 Other liquids that have both active hydrogen 
atom and donor atoms, but do not form three 
dimensional network [rather forming chainlike 
oligomers]. E.g. primary alcohols, carboxylic acid, 
primary and secondary amine, nitro- compounds, 
liquefied ammonia etc. They are generally called 
protic or protogenic substances.  
 
Class- 3 Liquid collected of molecules containing 
donor atoms, but no active hydrogen atoms, e.g. 
ether, ketones, aldehydes, esters, tertiary amines, 
nitro compounds without α-hydrogen. 
 
Class- 4 Liquid composed of molecules containing 
active hydrogen atoms but no donor atoms. e.g. 
chloroform and some aliphatic halides. 
 
Class-5 Liquid with no hydrogen bond forming 
capability and no donor atoms, e.g. hydrocarbons, 
carbon disulfide, carbon tetrachloride. [13] 
 
Protein Precipitation 
Protein precipitation is normally used for rapid 
sample clean-up and the disturbing protein drug 
binding. 
Four categories of protein precipitation techniques 
there are follows  
1) Organic solvent 
2) Acid  
3) Salt 
4) Metal ion 
 
Solubility results from polar interactions with 
aqueous solvent, ionic interactions through salts & 
repulsive electrostatic forces between like charged 
molecules. Precipitants apply exact effects on 
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proteins to enable their precipitation from liquid. 
Natural solvent [organic solvent] precipitant 
reduction the dielectric gone of the plasma protein 
solution, which growths the attraction between 
charged molecules and allows electrostatic protein 
interactions. The organic solvent similarly moves the 
orderly water molecules about the hydrophobic areas 
on the protein surface.[16] 
 
 
 
 
Stationary Phase selection  
The stationary phase is depending on some following 
parameter. 
 
Column selection  
Column is heart of separation process and they 
serious impact on method development and 
validation. Selection of column based upon 
knowledge of sample and goals of separation. The 
various factors including column selection follow as 
 
Diameter of Column  
Generally narrow diameter column is more sensitive 
so wider diameter column select greater sample 
loading. 
 
Particle size 
Smaller particle- 3-4μm 
Bigger particle- 5-10μm 
 
Selection of mobile phase 
Mobile phase is play important role in improving the 
peak area [Resolution] and improving peak 
sensitivity. In choose the rights match among 
stationary phase and mobile phase compositions, 
decrease total time of analysis and increase peak 
height. 
 
Buffer  
Buffer is important in mobile phase optimization, 
since retention time depending on the molar strength 
of buffer. 
 
pH of Buffer 
It is maintaining pH of mobile phase in the range of 
2-8 since column not withstand pH outside the range. 
Reason is the siloxane leakage area cleaved pH 2.00, 
while pH 8.00 above the silica is dissolved.[1] 
 
Method Validation 
Method validation can be defined [as per ICH 
Guidelines] as “Creating documented evidences, 
which provides a high degree of assurance that 
specific method or activity. 
 
Type of method validation  
A. Full validation  
B. Partial validation  
C. Cross validation 
 
Validation Parameter  
Selectivity 
At least 10 sources of plasma containing heparin and 
anticoagulant, including of  6 normal plasma. The 
response of the interfering peak at the retention time 
of analyte should be less than 20% of mean response 
of the processed LLOQ sample. 
 
Carry Over Effect 
Extract and analyze blank sample, LLOQ and ULOQ 
in single free source of plasma. First inject LLOQ 
sample and after inject ULOQ Sample. The response 
of the interfering peak at the retention time of analyte 
in the blank processed sample should be less than 
20% of the mean response of the processed LLOQ 
samples.[17]  
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PRECISION AND ACCURACY: 
Between and within batch precision and accuracy 
will be calculated by analyzing three PA batches. The 
accuracy of at least 67% of total QC samples must be 
within ± 15% of the respective nominal value except 
at LLQC level where it should be within ±20% of the 
respective nominal value.[18] 
 
Precision of QC samples at each level should be less 
than 15% except at LLQC level where it should be 
within less than 20%. 
 
Whole accuracy of QC samples at every level should 
be within ±15% except at LLQC level where it 
should be within ±20%.[19] 
 
RECOVERY: 
mean % recovery of analyte
=
mean peak area response of analyte in extracted samples
mean peak area response of analyte in aqueous samples
× 100 
Recovery for method need not be 100% but should be 
precise. 
The C.V. [%] of the mean analyte and internal 
standard recoveries must be less than 20% across all 
the three QC samples.[18] 
 
Matrix Effect   
It is important to consider the variability of matrix 
sample due to physiological nature of sample[6].  
%C.V. of average peak area ratios of post spiked 
LQCs and HQCs should not exceed 15%.[20] 
 
Stock solution stability 
Calculated % change should be within ± 10%. 
 
Long Term Stability 
At least 67% of the total number of Quality control 
samples and 50% of the quality control samples at 
each level should be within 85-115 % of their 
nominal value.[17] 
CONCLUSION: 
This review describes various aspects of the 
hyphenated technique; LC MS/MS, used for the 
bioanalysis. Bioanalytical method development and 
validation are required for the information of 
bioavailability and bioequivalence. These studies 
provide pharmacokinetic, toxicokinetic and metabolic 
data of drugs. Bioanalytical method development 
consists of sample preparation, chromatographic 
separation and detection by using LC MS/MS. 
Validation of a bioanalytical method comprises of 
various validation parameters which includes 
accuracy, precision, sensitivity, selectivity, standard 
curve, limits of quantification, range, recovery 
stability, etc. LC MS/MS is most widely used 
analytical technique for bioanalytical method 
development and validation. Bioanalysis by LC 
MS/MS provides low detection limits, good ability to 
generate structural information, minimal sample 
requirement and wider coverage of range of analytes 
different in their polarities. 
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